Aviso Financial Inc. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm purchased 1,436 shares of the semiconductor company's stock, valued at approximately $616,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of SNPS. Williams Jones Wealth Management LLC. increased its holdings in shares of Synopsys by 0.5% during the 4th quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company's stock worth $2,257,000 after buying an additional 22 shares during the last quarter. Hardy Reed LLC raised its position in Synopsys by 0.7% in the first quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company's stock valued at $1,411,000 after purchasing an additional 22 shares during the period. Resurgent Financial Advisors LLC raised its position in Synopsys by 2.7% in the first quarter. Resurgent Financial Advisors LLC now owns 832 shares of the semiconductor company's stock valued at $357,000 after purchasing an additional 22 shares during the period. Trust Asset Management LLC raised its position in Synopsys by 1.3% in the first quarter. Trust Asset Management LLC now owns 1,766 shares of the semiconductor company's stock valued at $757,000 after purchasing an additional 22 shares during the period. Finally, Harbour Investments Inc. raised its position in Synopsys by 10.8% in the first quarter. Harbour Investments Inc. now owns 235 shares of the semiconductor company's stock valued at $101,000 after purchasing an additional 23 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Performance
NASDAQ SNPS traded up $8.35 during trading hours on Friday, hitting $606.52. The company had a trading volume of 863,153 shares, compared to its average volume of 1,421,519. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a market cap of $94.11 billion, a PE ratio of 43.79, a price-to-earnings-growth ratio of 3.95 and a beta of 1.15. The business has a 50 day moving average of $567.73 and a 200-day moving average of $500.38.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter in the prior year, the firm posted $3.00 earnings per share. Synopsys's revenue for the quarter was up 10.3% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, equities research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Buying and Selling at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $457.93, for a total value of $5,204,832.38. Following the completion of the transaction, the chief executive officer owned 71,589 shares in the company, valued at $32,782,750.77. This represents a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the transaction, the executive owned 1,485 shares of the company's stock, valued at $699,746.85. This represents a 85.85% decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,686 shares of company stock worth $13,001,048 over the last 90 days. Corporate insiders own 0.62% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have issued reports on SNPS shares. Piper Sandler boosted their target price on Synopsys from $615.00 to $660.00 and gave the company an "overweight" rating in a research report on Monday, July 21st. KeyCorp boosted their target price on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a research report on Thursday, July 10th. The Goldman Sachs Group started coverage on Synopsys in a research report on Thursday, July 10th. They issued a "buy" rating and a $620.00 target price on the stock. Morgan Stanley reissued an "overweight" rating and issued a $715.00 target price (up previously from $540.00) on shares of Synopsys in a research report on Monday, August 11th. Finally, Bank of America boosted their target price on Synopsys from $575.00 to $625.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Twelve research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, Synopsys currently has a consensus rating of "Moderate Buy" and an average target price of $626.79.
Check Out Our Latest Analysis on Synopsys
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.